Skip to content
← Back to this collection

PUBLICATIONS · 33460574

Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2021 Feb
First author
Mayer EL

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Feb;22(2):159-160. doi: 10.1016/S1470-2045(20)30757-9.
    note
    Source null
    related pmid
    33460573
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2022 Feb;23(2):195-197. doi: 10.1016/S1470-2045(21)00708-7.
    note
    Source null
    related pmid
    35114114
    relationship
    Comment in

Authors and identifiers

  1. name
    Mayer EL
    type
    Author
  2. name
    Dueck AC
    type
    Author
  3. name
    Martin M
    type
    Author
  4. name
    Rubovszky G
    type
    Author
  5. name
    Burstein HJ
    type
    Author
  6. name
    Bellet-Ezquerra M
    type
    Author
  7. name
    Miller KD
    type
    Author
  8. name
    Zdenkowski N
    type
    Author
  9. name
    Winer EP
    type
    Author
  10. name
    Pfeiler G
    type
    Author
  11. name
    Goetz M
    type
    Author
  12. name
    Ruiz-Borrego M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mayer EL
    type
    Author
  2. name
    Dueck AC
    type
    Author
  3. name
    Martin M
    type
    Author
  4. name
    Rubovszky G
    type
    Author
  5. name
    Burstein HJ
    type
    Author
  6. name
    Bellet-Ezquerra M
    type
    Author
  7. name
    Miller KD
    type
    Author
  8. name
    Zdenkowski N
    type
    Author
  9. name
    Winer EP
    type
    Author
  10. name
    Pfeiler G
    type
    Author
  11. name
    Goetz M
    type
    Author
  12. name
    Ruiz-Borrego M
    type
    Author
bibliography ids
  1. nci-bib-11f96448d22452848e7a156d
book metadata
content sha256
542c6e7865460cc4904944e6e9be451b612b6ab90ef3ff454542b3bb5017e288
document type
citation
dois
  1. 10.1016/S1470-2045(20)30642-2
electronic publication date
display
2021 Jan 15
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:33460574
immutable id
pubmed:33460574@542c6e7865460cc4904944e6e9be451b612b6ab90ef3ff454542b3bb5017e288
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
2
name
The Lancet. Oncology
nlm unique id
100957246
pages
212-222
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Feb;22(2):159-160. doi: 10.1016/S1470-2045(20)30757-9.
    note
    Source null
    related pmid
    33460573
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2022 Feb;23(2):195-197. doi: 10.1016/S1470-2045(21)00708-7.
    note
    Source null
    related pmid
    35114114
    relationship
    Comment in
outcomes validated
false
pmid
33460574
provenance
batch id
9bca82d1bba2b27adc79
provider
NCBI PubMed ESummary
record sha256
337512fe1559b7b3083c531b73f0f49bd07dc6cb21990cd2b28c147bee28cba4
response sha256
c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
retrieved at
2026-09-09T23:47:56.131551+00:00
publication date
display
2021 Feb
precision
month
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33460574/
title
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.

Preserved source evidence · Not medical advice